Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.14479 | 47 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.12504 | 48 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.11619 | 47 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.07637 | 48 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.07534 | 48 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.12446 | 44 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.12865 | 45 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.10639 | 47 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.2207 | 51 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.11707 | 48 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.11318 | 47 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.10159 | 48 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.12019 | 47 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.11787 | 48 |